Gentian Diagnostics ASA reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was NOK 23.07 million compared to NOK 17.18 million a year ago. Revenue was NOK 25.09 million compared to NOK 19.36 million a year ago. Net loss was NOK 9.38 million compared to NOK 6.78 million a year ago. Basic loss per share from continuing operations was NOK 0.61 compared to NOK 0.44 a year ago.
For the nine months, sales was NOK 73.73 million compared to NOK 61.39 million a year ago. Revenue was NOK 81.05 million compared to NOK 75.07 million a year ago. Net loss was NOK 18.99 million compared to NOK 15.22 million a year ago.